India’s AI Unicorn Krutrim Pivots Toward Cloud Infrastructure Amid Strategic Realignment
, , ,

India’s AI Unicorn Krutrim Pivots Toward Cloud Infrastructure Amid Strategic Realignment

Krutrim, the Bengaluru-based startup recognized as India’s first generative AI unicorn, is undergoing a significant strategic shift. After months of reduced public visibility and a pause in its ambitious chip development efforts, the company is pivoting its primary focus toward providing AI cloud services. This transition follows a major business restructuring in late 2025, which […]

Geely’s Strategic Play: Building an American Automotive Footprint Through Established Brands
, , ,

Geely’s Strategic Play: Building an American Automotive Footprint Through Established Brands

Zhejiang Geely Holding Group is effectively maneuvering through the complex American automotive landscape, despite facing significant political opposition and steep tariffs on Chinese-made electric vehicles. Rather than relying on traditional direct-import models, the conglomerate has secured a presence in the U.S. by leveraging its ownership stakes in well-known Western brands. By controlling companies such as […]

Paramount Skydance Defies Industry Trends with Strong First Quarter Gains
, , ,

Paramount Skydance Defies Industry Trends with Strong First Quarter Gains

Paramount Skydance has kicked off the fiscal year with a performance that outperformed analyst expectations, highlighting a successful pivot toward digital media. The entertainment conglomerate reported quarterly revenue reaching $7.35 billion, marking a 2% year-over-year growth. This upward trajectory was fueled largely by the company’s streaming services and a resilient film studio division, proving that […]

The Oral GLP-1 Race: Novo Nordisk and Eli Lilly Battle for Weight-Loss Dominance
, , ,

The Oral GLP-1 Race: Novo Nordisk and Eli Lilly Battle for Weight-Loss Dominance

The landscape of weight-loss treatments is undergoing a significant transformation as pharmaceutical giants Novo Nordisk and Eli Lilly compete to capture the burgeoning oral GLP-1 medication market. Novo Nordisk gained an early advantage with the launch of its Wegovy pill, which has seen rapid adoption among patients previously wary of injectable treatments. The introduction of […]